Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela M Starks

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Tuberculosis Research and Treatment|March 21, 2015
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosisMitchell A Yakrus, Beverly Metchock, Angela M Starks
Journal of Microbiology (Seoul, Korea)|March 15, 2005
Molecular Pathogenesis of Vibrio vulnificusPaul A Gulig, Keri L Bourdage, Angela M Starks
Expert Review of Molecular Diagnostics|November 7, 2014
Evaluation of the Cepheid Xpert MTB/RIF assayThomas M Shinnick, Angela M Starks, Heather L Alexander, et al.
Journal of Bacteriology|December 15, 2005
Assembly of CS1 pili: the role of specific residues of the major pilin, CooAAngela M Starks, Barbara J Froehlich, Tamara N Jones, et al.
Molecular Microbiology|July 22, 2006
Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected miceAngela M Starks, Keri L Bourdage, Patrick C Thiaville, et al.
Public Health Reports (Washington, D.C. : 1974)|November 12, 2015
Representativeness of Tuberculosis Genotyping Surveillance in the United States, 2009-2010Emma B Shak, Anne Marie France, Lauren Cowan, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosisAngela M Starks, Aysel Gumusboga, Bonnie B Plikaytis, et al.
Open Forum Infectious Diseases|May 13, 2022
Use of Nucleic Acid Amplification Testing for Rapid Detection of <i>Mycobacterium tuberculosis</i> Complex Among US Tuberculosis Patients, 2011‒2017Varsha Kumar, Tracy L Dalton, Lori R Armstrong, et al.
Tuberculosis Research and Treatment|July 5, 2016
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United StatesMitchell A Yakrus, Jeffrey Driscoll, Allison McAlister, et al.
Journal of Clinical Microbiology|March 21, 2014
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United StatesMitchell A Yakrus, Jeffrey Driscoll, Allison J Lentz, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Tuberculosis Research and Treatment|March 21, 2015
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosisMitchell A Yakrus, Beverly Metchock, Angela M Starks
Journal of Microbiology (Seoul, Korea)|March 15, 2005
Molecular Pathogenesis of Vibrio vulnificusPaul A Gulig, Keri L Bourdage, Angela M Starks
Expert Review of Molecular Diagnostics|November 7, 2014
Evaluation of the Cepheid Xpert MTB/RIF assayThomas M Shinnick, Angela M Starks, Heather L Alexander, et al.
Journal of Bacteriology|December 15, 2005
Assembly of CS1 pili: the role of specific residues of the major pilin, CooAAngela M Starks, Barbara J Froehlich, Tamara N Jones, et al.
Molecular Microbiology|July 22, 2006
Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected miceAngela M Starks, Keri L Bourdage, Patrick C Thiaville, et al.
Public Health Reports (Washington, D.C. : 1974)|November 12, 2015
Representativeness of Tuberculosis Genotyping Surveillance in the United States, 2009-2010Emma B Shak, Anne Marie France, Lauren Cowan, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosisAngela M Starks, Aysel Gumusboga, Bonnie B Plikaytis, et al.
Open Forum Infectious Diseases|May 13, 2022
Use of Nucleic Acid Amplification Testing for Rapid Detection of <i>Mycobacterium tuberculosis</i> Complex Among US Tuberculosis Patients, 2011‒2017Varsha Kumar, Tracy L Dalton, Lori R Armstrong, et al.
Tuberculosis Research and Treatment|July 5, 2016
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United StatesMitchell A Yakrus, Jeffrey Driscoll, Allison McAlister, et al.
Journal of Clinical Microbiology|March 21, 2014
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United StatesMitchell A Yakrus, Jeffrey Driscoll, Allison J Lentz, et al.
Pageof 3